Bicara Therapeutics Inc (NASDAQ:BCAX)’s traded shares stood at 0.48 million during the last session. At the close of trading, the stock’s price was $13.24, to imply an increase of 1.15% or $0.15 in intraday trading. The BCAX share’s 52-week high remains $28.09, putting it -112.16% down since that peak but still an impressive 16.16% since price per share fell to its 52-week low of $11.10. The company has a valuation of $720.46M, with an average of 0.75 million shares in intraday trading volume over the past 10 days and average of 426.34K shares over the past 3 months.
Bicara Therapeutics Inc (NASDAQ:BCAX) trade information
After registering a 1.15% upside in the last session, Bicara Therapeutics Inc (BCAX) has traded red over the past five days. The 5-day price performance for the stock is 6.60%, and -4.20% over 30 days. With these gigs, the year-to-date price performance is -24.00%. Short interest in Bicara Therapeutics Inc (NASDAQ:BCAX) saw shorts transact 5.61 million shares and set a 15.48 days time to cover.
The extremes give us $35 and $35 for target low and target high price respectively. As such, BCAX has been trading -164.35% off suggested target high and -164.35% from its likely low.
BCAX Dividends
Bicara Therapeutics Inc has its next earnings report out on 2024-Nov-11. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Bicara Therapeutics Inc (NASDAQ:BCAX)’s Major holders
Bicara Therapeutics Inc insiders hold 0.43% of total outstanding shares, with institutional holders owning 86.06% of the shares at 86.43% float percentage. In total, 86.06% institutions holds shares in the company.
We also have Vanguard Total Stock Market Index Fund and T. Rowe Price New Horizons Fund, Inc. as the top two Mutual Funds with the largest holdings of the Bicara Therapeutics Inc (BCAX) shares. Going by data provided on Dec 31, 2024 , Vanguard Total Stock Market Index Fund holds roughly 636.55 shares. This is just over 1.17% of the total shares, with a market valuation of $8.43 million. Data from the same date shows that the other fund manager holds a little less at 589.03, or 1.08% of the shares, all valued at about 7.8 million.
